Clinical Trial Update: Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating lixisenatide in type 2 diabetes patients who failed other GLP-1 therapies has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Adlyxin (lixisenatide)

Snippet

Sponsor: Laniado Hospital | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: TERMINATED